Virtual Reality Analgesia During Pediatric Physical Therapy
VRD/Peds
1 other identifier
interventional
18
1 country
1
Brief Summary
We would like to determine whether Virtual Reality (VR) analgesia continues to be effective for reducing pain when administered for a clinically relevant treatment duration over multiple, repeated exposures (i.e., up to ten sessions of physical therapy per patient).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2009
CompletedFirst Submitted
Initial submission to the registry
October 13, 2009
CompletedFirst Posted
Study publicly available on registry
October 14, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedMarch 13, 2019
March 1, 2019
7.9 years
October 13, 2009
March 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain and anxiety
pre and post procedure
Study Arms (3)
VR during Physical Therapy
EXPERIMENTALThe subject will receive virtual reality during painful physical therapy sessions.
VR background pain
EXPERIMENTALThe subjects receives virtual reality, not during a physical therapy procedure, another time of the day for background pain.
No VR
EXPERIMENTALThe subject will receive the usual standard treatment. At the end of the study, before being discharged from the hospital, the subject can experience the VR, not during a procedure.
Interventions
Virtual Reality will be performed during a painful physical therapy procedure.
Virtual Reality is used at anytime during the day for the background pain, not during physical therapy.
The subject will receive the usual standard treatment. At the end of the study, before being discharged from the hospital, the subject can experience the VR, not during a procedure.
Eligibility Criteria
You may qualify if:
- Age greater than or equal to 8 years up to 20 yrs old
- Compliant and able to complete subject evaluation
- A minimum of 3 days of physical therapy, one physical therapy session per day
- No history of psychiatric (DSM-IV-R Axis I) or developmental disorder that would interfere with decisional capacity
- Not demonstrating delirium, psychosis, or any form of Organic Brain Disorder that would interfere with decisional capacity
- Able to communicate verbally
- Able to take oral medications
- English-speaking
You may not qualify if:
- \- Age less than 8 years, or greater than 20 years.
- Not capable of indicating pain intensity
- Not capable of filling out study measures
- Hospitalization of fewer than 3 days
- Evidence of traumatic brain injury
- History of psychiatric (DSM-IV-R Axis I) disorder as evidenced in the admitting RN and MD admission notes, if interfering with decisional capacity
- Demonstrating delirium, psychosis or any form of Organic Brain Disorder and associated memory problems that would interfere with decisional capacity
- Unable to communicate verbally
- Unable to take oral medications
- History of sig. cardiac, endocrine, neurologic, metabolic, respiratory, gastrointestinal or genitourinary impairment that would interfere with treatment or decisional capacity
- Receiving prophylaxis for alcohol or drug withdrawal
- Developmental disability that would interfere with decisional capacity
- Face/head/neck injuries preventing helmet use
- Non-English-speaking
- Extreme susceptibility to motion sickness
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Harborview Medical Center
Seattle, Washington, 98104-2499, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David R Patterson, Ph.D.
University of Washington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD.ABPP. Professor
Study Record Dates
First Submitted
October 13, 2009
First Posted
October 14, 2009
Study Start
May 1, 2009
Primary Completion
April 1, 2017
Study Completion
April 1, 2017
Last Updated
March 13, 2019
Record last verified: 2019-03